Amoxycillin

PreclinicalSmall molecule

MMenzies School of Health Research

Amoxycillin is one of 37 small molecule programs targeting Age. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AgeCompleted

AgePreclinical

Completed

Competition

Competitive Landscape

49 competitors in Age

#DrugCompanyPhaseTrials

Actigall

AbbVie

Approved

—2

Rapamune

PPrism Pharmaceuticals

Approved

—3

Decadron

AAspen Global Incorporated

Phase 2

3 4

Sarclisa

AAzienda U.S.L. 1 di Massa e Carrara

Phase 2

1 5

Rezurock

KKadmon, a Sanofi Company

Phase 2

1 6

Venclexta

AbbVie

Phase 1

3 7

Acotiamide

GGetz Pharma

Phase 3

1 8

APG-2575

Ascentage Pharma Group Inc.

Phase 2

1 9

Evorpacept

AALX Oncology Inc.

Phase 2

1 10

APG-115

Ascentage Pharma Group Inc.

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Otitis media1 trial

Long-term Antibiotics for Treatment and Prevention of Otitis Media in Aborignal Children

Completed·MMenzies School of Health Research·Phase 4·NCT00539149·126 enrolled

Pneumonia1 trial

Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze

Completed·KKing George's Medical University·Phase 3·NCT00407394·2,000 enrolled

Age1 trial

Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs

Completed·—·N/A·NCT00720811·6,456 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Amoxycillin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Amoxycillin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Amoxycillin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Menzies School of Health Research company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMenzies School of Health Research

Amoxycillin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Otitis media1 trial

Pneumonia1 trial

Age1 trial

References

Drug Info

Quick Facts

Related News